SEC Form 4 · accession 0001209191-15-035581
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephanie Monaghan OBrien
Director
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 20, 2015 | P | 1,700 | $17.00 | A | 1,700 | D | |
| Common StockF1 | Apr 20, 2015 | P | 1,700 | $17.00 | A | 1,700 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.